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Abstract:
Thiamine is a water-soluble vitamin. Thiamine deficiency can present as a central nervous system disorder known 
as Wernicke’s encephalopathy, which classically manifests as confusion, ataxia, and ophthalmoplegia. Wernicke’s 
encephalopathy has rarely been reported following hematopoietic stem cell transplantation. Herein, we report 
Wernicke’s encephalopathy in a patient with acute myeloid leukemia who had been receiving prolonged total parenteral 
nutrition after haploidentical allogeneic hematopoietic stem cell transplantation. To the best of our knowledge, this is 
the first case reported from Turkey in the literature.
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Öz:
Tiamin suda çözünen bir vitamindir. Tiamin eksikliği Wernicke ensefalopatisi olarak bilinen, klasik olarak konfüzyon, 
ataksi ve oftalmopleji ile kendini gösteren bir merkezi sinir sistemi hastalığı olarak karşımıza çıkabilir. Hematopoetik 
kök hücre nakli sonrasında gelişen Wernicke ensefalopatisi nadiren bildirilmiştir. Bu nedenle haploidentik allojenik 
kök hücre naklinden sonra uzun süre total parenteral beslenme alan akut myeloid lösemili bir hastada gelişen Wernicke 
ensefalopatisini sunmak istedik. Bildiğimiz kadarıyla literatürde Türkiye’den bildirilen ilk olgudur.
Anahtar Sözcükler: Tiamin, Wernicke ensefalopatisi, Hematopoetik kök hücre nakli, Total parenteral beslenme
A Rare Complication Developing After Hematopoietic Stem 
Cell Transplantation: Wernicke’s Encephalopathy
Hematopoetik Kök Hücre Nakli Sonrası Gelişen Nadir Bir 
Komplikasyon: Wernicke Ensefalopatisi
DOI: 10.4274/tjh.2014.0412
Turk J Hematol 2015;32:367-370
368
Turk J Hematol 2015;32:367-370
Introduction
Thiamine is a water-soluble vitamin also known as 
vitamin B1 [1]. Thiamine deficiency can present as a central 
nervous system (CNS) disorder known as Wernicke’s 
encephalopathy (WE), which classically manifests as 
confusion, ataxia, and ophthalmoplegia [1,2]. The disease 
is most frequently associated with chronic alcoholism, yet it 
can also occur in relation to other forms of malnutrition or 
malabsorption such as prolonged total parenteral nutrition 
(TPN), total gastrectomy, gastrojejunostomy, severe anorexia, 
or hyperemesis gravidarum [3]. Hematopoietic stem cell 
transplantation (HSCT) does not seem to have a strong link 
with WE [4]. To the best of our knowledge, this is the first 
such case reported from Turkey in the literature and wanted 
to report this case due to its rarity.
Case Presentation
A 19-year-old male patient diagnosed with acute myeloid 
leukemia was admitted to our hospital for HSCT. After 
remission had been achieved, he underwent haploidentical 
HSCT from a sibling donor with a busulfan-fludarabine 
conditioning regimen. During the conditioning period, the 
patient was administered TPN, which is routinely used in 
haploidentical HSCT; however, he developed grade 2-3 nausea 
and vomiting and could not tolerate TPN. His oral intake was 
also insufficient, so he received saline solution and glucose-
containing intravenous solutions. He gradually recovered 
from neutropenia on day 13 after HSCT without any adverse 
events.
He was hospitalized due to diarrhea and vomiting 3 weeks 
after the transplantation. On follow-up, toxic megacolon 
and cytomegalovirus positivity were detected, so ganciclovir 
treatment was started and oral intake was restricted until 
recovery of intestinal symptoms. Efforts were made to feed 
the patient by TPN with the aim of meeting his caloric needs 
although he could not initially tolerate it. He was examined 
for acute graft-versus-host disease (GVHD); he underwent 
colonoscopy and pathologic samples were obtained, but 
this examination did not reveal histological findings of 
GVHD. Three weeks after his hospitalization, he developed 
confusion, hallucination, strabismus, and nystagmus. A 
neurology consultation was therefore done. In his neurologic 
examination, he was oriented to place and person, but not to 
time. He had horizontal nystagmus and lateral gaze paralysis 
in the right eye, his motor power was 4/5, deep tendon reflexes 
were hypoactive, Babinski reflex was negative bilaterally, he 
could not cooperate with cerebellar tests, and he could not 
stand up. Magnetic resonance imaging (MRI) of the brain 
showed increased signal on T2-weighted and fluid-attenuated 
inversion recovery (FLAIR) sequences around the aqueductus 
sylvii and at the medial parts of both thalami (Figures 1a and 
1b). A prediagnosis of WE was made based on the patient’s 
history of inadequate oral intake and TPN use, CNS symptoms, 
and specific radiologic findings. A blood sample was obtained 
for testing serum thiamine level to confirm the diagnosis 
before initiating therapy. Thereafter, 125 mg of thiamine 
was intravenously administered daily, resulting in a rapid 
improvement of the CNS symptoms within 48 h of treatment, 
and parenteral treatment continued for 2 weeks. Serum 
thiamine level was reported as 7.5 µg/L (normal range: 25-75 
µg/L), verifying our diagnosis. During follow-up, his neurologic 
findings and oral intake gradually improved, and so medical 
therapy was switched to peroral treatment and maintained 
with 250 mg of daily peroral thiamine. MRI revealed that the 
previous increased signal around the aqueductus sylvii and at 
the medial parts of both thalami on T2-weighted and FLAIR 
sequences had significantly diminished (Figures 2a and 2b). 
Informed consent was obtained.
Discussion and Review of the Literature 
Neurological complications are fairly common in patients 
undergoing HSCT and are present in 30%-39% of cases [5]. 
These complications may be of infectious, cerebrovascular, 
toxic, immune-mediated, or metabolic origin [5]. Additionally, 
several drugs routinely used during HSCT are associated with 
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Figure 1a. Axial fluid-attenuated inversion recovery magnetic 
resonance imaging images of the brain demonstrating the 
increased signal around the aqueductus sylvii.
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neurological abnormalities, including cyclosporine A [5] and 
tacrolimus [6]. Used alone or in combination with other agents, 
methylprednisolone and ganciclovir may be responsible 
for neurological findings, including disorientation, altered 
mental status, visual disturbance, and coma [5]. We think 
that we saved some time in making a differential diagnosis 
by examining serum tacrolimus level to exclude drug toxicity 
and cerebrovascular causes. 
WE is characterized by the triad of altered mental status, 
ataxia, and ophthalmoplegia, but only 16% of patients present 
with the full classic triad of symptoms [5]. Mental status 
changes are the most frequent findings in these patients 
(82%), followed by ocular findings (29%) and ataxia (23%) 
[5]. Ocular signs, including ophthalmoplegia, horizontal 
and vertical nystagmus, and conjugate gaze palsies, are the 
hallmark of WE [3]. Although almost all WE patients show 
some degree of improvement after initiation of thiamine 
replacement, only about 20% recover completely [4]. 
Furthermore, mortality increases dramatically when treatment 
is delayed [4]. According to the guidelines of the European 
Federation of Neurological Societies, total thiamine in blood 
samples should be measured immediately before thiamine 
administration to confirm suspected or manifest WE and MRI 
should be used to support diagnosis [7]. Fortunately, we could 
make a timely diagnosis based on clinical and radiological 
findings and supported by decreased thiamine level thereafter, 
and thus we could prevent mortality. 
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Figure 1b. Axial fluid-attenuated inversion recovery magnetic 
resonance imaging images of the brain demonstrating the 
increased signal at the medial parts of both thalami.
Figure 2a. Control magnetic resonance imaging 2 weeks after 
the onset of the symptoms; fluid-attenuated inversion recovery 
image showing the diminution of increased signal around the 
aqueductus sylvii.  
Figure 2b. Control magnetic resonance imaging 2 weeks after 
the onset of the symptoms; fluid-attenuated inversion recovery 
image showing the diminution of increased signal at the medial 
parts of both thalami. 
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Patients receiving long-term TPN and glucose-containing 
intravenous solutions require larger amounts of thiamine 
to metabolize their carbohydrate intake, which can rapidly 
deplete thiamine stores [3]. Studies show that a state of 
depletion could develop within 18-20 days in patients 
receiving a strict thiamine-free diet [5]. Almost all published 
reports, except for one, concluded that prolonged TPN was the 
primary risk factor for HSCT-associated WE [4]. Our patient 
had received TPN for approximately 4-5 weeks in total. TPN 
includes multivitamin and mineral supplementation in our 
routine treatment protocol. However, we could not administer 
it in this patient due to temporary lack of the concerned drugs 
in the pharmacy of the hospital. The only other suggested 
cause was the use of busulfan in the conditioning regimen 
[4]. Similarly to data in the literature, our patient received 
busulfan in the conditioning regimen and thiamine-free TPN, 
and symptoms of WE emerged from day +45. 
Many authors have recommended the use of a thiamine 
supplement for prophylaxis against WE [4]. However, an 
earlier publication from a Brazilian group reported 8 patients 
who died after developing WE despite receiving prophylactic 
thiamine (50 mg/day) [4]. Further studies are required to 
decide on an effective prophylactic dose of thiamine and to 
determine whether thiamine prophylaxis is effective in the 
prevention of WE in HSCT patients [4]. This case taught us the 
vital importance of vitamin supplementation in patients who 
need long-term TPN. Based on these findings, we reviewed our 
institutional policy about vitamin supplementation in TPN 
and began adding water-soluble vitamins into TPN solutions 
individually if combination preparations were not available in 
the pharmacy of the hospital. 
There are not routine recommendations for initial CNS 
evaluation and management of the rarely occurring WE [4]. 
However, WE is a neurological emergency [8]. Therefore, 
WE should be considered in HSCT patients, because cancer 
patients are at high risk of this acute encephalopathy due 
to chronic malnutrition, chemotherapy-induced nausea and 
vomiting, and consumption of thiamine by rapidly growing 
tumors [8]. 
In conclusion, differential diagnosis should consider WE 
for patients who undergo HSCT and develop neurological 
symptoms. Early treatment prevents high morbidity and 
mortality. Therefore, thiamine supplements should be 
administered to patients at high risk for WE. 
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